Teza Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,681
| Closed | -$477K | – | 754 |
|
|
2024
Q1 | $477K | Buy |
+3,681
| New | +$477K | 0.06% | 346 |
|
|
2023
Q4 | – | Sell |
-4,668
| Closed | -$566K | – | 742 |
|
|
2023
Q3 | $566K | Buy |
+4,668
| New | +$566K | 0.09% | 294 |
|
|
2023
Q1 | – | Sell |
-3,587
| Closed | -$465K | – | 697 |
|
|
2022
Q4 | $465K | Sell |
3,587
-1,526
| -30% | -$198K | 0.09% | 343 |
|
|
2022
Q3 | $565K | Buy |
5,113
+1,585
| +45% | +$175K | 0.12% | 253 |
|
|
2022
Q2 | $264K | Buy |
+3,528
| New | +$264K | 0.1% | 335 |
|
|
2021
Q3 | – | Sell |
-11,104
| Closed | -$863K | – | 572 |
|
|
2021
Q2 | $863K | Buy |
+11,104
| New | +$863K | 0.14% | 196 |
|
|
2020
Q3 | – | Sell |
-10,049
| Closed | -$1.61M | – | 593 |
|
|
2020
Q2 | $1.61M | Buy |
+10,049
| New | +$1.61M | 0.36% | 66 |
|